Earl N. Metz - Concepedia

Author

Earl N. Metz

The Ohio State University

Also Known As

E Metz, E N Metz, E. Metz, E. N. Metz, EARL METZ, EARL N. METZ, Earl Metz, Earl N. Metz, Ellie Metz, Emily Metz

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Ohio State University Hospital Duke Medical Center University of Arkansas Medical Center University of Mississippi Medical Center

About

Earl N. Metz is an author at The Ohio State University specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.3K
2	Health Sciences	4	4	227
3	Biochemistry	4	4	541
4	Allergy	1	1	132
5	Anatomy	1	1	21

Earl N. Metz

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase Gertrude B. Elion, Aylene Kovensky, George H. Hitchings, Biochemical Pharmacology OxysterolBiochemistryMedicineLipid PeroxidationMetabolism	1966	331
Allopurinol in the Treatment of Gout R. Wayne Rundles, Earl N. Metz, H Silberman Annals of Internal Medicine Molecular PharmacologyMedicinal ChemistryUrologyUric AcidArticle1 February 1966Allopurinol	1966	240
Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study Stephen E. Jones, P Grozea, Earl N. Metz, Cancer	1979	156
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy KK Hussein, Steve Dahlberg, David Head, Blood	1989	132
A comparison of the metabolic response to phagocytosis in human granulocytes and monocytes. Arthur L. Sagone, Gerald W. King, Earl N. Metz Journal of Clinical Investigation Lipid PeroxidationImmunologyBlood CellRedox BiologyCellular Physiology	1976	132
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy KK Hussein, Steve Dahlberg, David Head, Blood	1989	115
Leukemic reticuloendotheliosis Gerald W. King, Paul E. Hurtubise, Arthur L. Sagone, The American Journal of Medicine	1975	99
Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity. Jane M. Leiby, K. Matthew Snider, Eric H. Kraut, PubMed Lymphoid NeoplasiaPhase Ii TrialRadiation TherapyMedicineDeoxycytidine Kinase Activity	1987	93
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study. Laurence Elias, Donna Stock-Novack, David R. Head, PubMed	1993	63
Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study Stephen E. Jones, P Grozea, Earl N. Metz, Cancer Hematological MalignancyLymphoid NeoplasiaLarge Cell LymphomaMedicineMalignant Blood Disorder	1983	55

Page 1